What's in a Picture: Scans for Lymphoma Recurrence
Despite the lack of data to justify them, periodic surveillance PET scans during remission are performed frequently.
Read More
B-Cell Lymphomas: A Long and Winding Road
For patients with B-cell lymphomas, new treatments are providing more options.
Finding the Positives in Negative Results
Researchers need to learn more about the biology of liver cancer to develop better treatments.
Gradual Gains in Liver Cancer
Refined treatments and targeted drugs signal slow yet significant progress for liver cancer.
Taking Immune Action Against Lung Cancer
One alternative to targeting specific tumor-associated proteins is to entice the patient’s immune system to attack the tumor directly.
Research Reveals New Frontiers in Lung Cancer
Focusing on screening and genetic clues, progress in lung cancer shifts forward.
Triple-Negative Breast Cancer: Divide and Conquer
Understanding the molecular makeup of triple-negative breast cancer reveals new therapeutic targets.
Not So Scary Anymore
With more knowledge, triple-negative breast cancer doesn't seem so scary.
Treating Multiple Myeloma From Every Angle
New treatments for multiple myeloma target the disease in different ways.
Sarcoma in the Young
Sarcoma is more common in children and young adults.
Group Therapy: Treatment Advances in Sarcoma
Soft tissue sarcoma has benefited from research in other cancers.
The Estrogen Effect: New Ways to Treat Hormone-Positive Breast Cancer
Patients whose breast cancers are estrogen-positive have a wide variety of treatments available.
Drugs First, Surgery Later?
Neoadjuvant breast cancer therapy may be beneficial.
Rx-Fueled Anger
Some drugs used to treat cancer can trigger physiological responses that manifest in feelings of anger.
Seeing Red: Coping with Anger During Cancer
Coping with anger during cancer can be difficult.
Advances in Bladder Cancer Treatment Around the Corner
New treatments for bladder cancer may be nearing the finish line.
Be Your Own Best Advocate When it Comes to Bladder Cancer
Advocating for yourself.
Brighter Horizons for Hodgkin Lymphoma Patients
The latest advancements in the treatment of Hodgkin lymphoma.
It's Only the Good Cancer If You're Cured
Although called a "good" cancer, Hodgkin lymphoma isn't always curable.
Does Treatment Differ for Older Patients?
Half of adult patients diagnosed with non-Hodgkin lymphoma are over age 60--oncologists must take into account age and associated complications.
Bittersweet Gene
Predicting drug response in colorectal cancer.
KRAS as a Target
KRAS gene mutations are detected in various cancers, including colorectal.
For the Caregiver: Life after Colorectal Cancer Surgery
Issues after surgery can be taxing for patient and caregiver.
In Whose Best Interest?
Exposing the ethical dilemmas of clinical trials reveals a balance between researchers, drug companies, and patients.
The End Is Just the Beginning
Data collection doesn’t end when a clinical trial ends, as rare or long-term side effects of a new drug or treatment may take years to emerge.
When Illnesses Compete
In an aging population, cancer is rarely a solo act.